The CAPS Screen: Playing Defense

Recs

3

Motley Fool Stock Advisor

Since 2002, David and Tom Gardner have returned 26.63% while the S&P 500 returned -12.56%. Try Stock Advisor free for 30 days.

Stock Advisor

Standard & Poor's research shows that consumer staples, utilities, health care, and financials outperform the market 80% to 90% of the time during recessions. As my Foolish colleagues Tim Hanson and Brian Richards point out, this outperformance is due to their reliability and healthy dividend policies.

Among large caps, this strategy held up extremely well during the last recession: Most of the top performers -- including Wal-Mart (NYSE: WMT) and Abbot Labs (NYSE: ABT) -- were defensive dividend payers.

With that in mind, I used our new CAPS screening tool to discover which defensive stocks our 115,000-member CAPS investment community loves most.

These stocks have:

  • Market capitalizations greater than $10 billion.
  • Dividend payments.
  • Four- or five-star ratings from our CAPS community (from a max of five).

Remember, since we first began collecting data in November 2006, CAPS' five-star companies outperformed the market with an average gain of 12.1% annually, while four-star stocks excelled by 7.1% annually.

Company

Share Price

Sector

Market Cap (in Billions)

Dividend Yield

Anheuser-Busch (NYSE: BUD)

$68.11

Consumer Goods

$49.0

2.2%

AT&T (NYSE: T)

$30.97

Technology

$182.4

5.2%

Kraft (NYSE: KFT)

$32.80

Consumer Goods

$49.8

3.3%

McDonald's (NYSE: MCD)

$65.67

Services

$73.5

2.3%

GlaxoSmithKline (NYSE: GSK)

$48.44

Health Care

$124.9

4.3%

Data from Motley Fool CAPS and Yahoo! Finance as of Aug. 8.

Of course, screens are merely a first step in the stock-selection process. As Miguel de Cervantes -- whose overly idealistic Don Quixote flails impulsively after unachievable dreams -- reminds us, "Diligence is the mother of good fortune." Come and join us on Motley Fool CAPS to dig into these companies further. Let our 115,000-strong (and counting) CAPS community help you polish your portfolio.

Further well-armored Foolishness:

Follow along with the Global Gains team as they travel to key business centers in China to uncover the very best investing opportunities! Sign up here to receive their FREE dispatches from the road.

At the time of publication, Ilan Moscovitz owned shares of Abbot. GlaxoSmithKline and Kraft are Income Investor selections. Wal-Mart is an Inside Value pick. The Motley Fool has a disclosure policy.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 704699, ~/articles/ArticleHandler.aspx, 7/13/2009 5:09:21 AM

Keep Reading:

“The CAPS Screen: Playing Defense”

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

What Fools Are Saying

Get involved! »

Most Recent

Jul 10 at 4:03 PM

Market Summary

DJIA 8,146.52 -36.65 -0.45%
S&P 500 879.13 -3.55 -0.40%
NASD 1,756.03 +3.48 +0.20%
Sponsored by:

Related Tickers

Abbott Laboratories

CAPS Rating 5/5 Stars

$45.41

-0.52 (-1.13%)

Outperform1357

Underperform72

Rate This Stock